loadpatents
Patent applications and USPTO patent grants for Anantharamaiah; Gattadahalli M..The latest application filed is for "apoe mimetic peptides and higher potency to clear plasma cholesterol".
Patent | Date |
---|---|
ApoE mimetic peptides and higher potency to clear plasma cholesterol Grant 10,653,747 - Anantharamaiah , et al. | 2020-05-19 |
Apoe Mimetic Peptides And Higher Potency To Clear Plasma Cholesterol App 20170209537 - Anantharamaiah; Gattadahalli M. ;   et al. | 2017-07-27 |
Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use App 20160271212 - Anantharamaiah; Gattadahalli M. ;   et al. | 2016-09-22 |
Synthetic apolipoprotein E mimicking polypeptides and methods of use Grant 9,422,363 - Anantharamaiah , et al. August 23, 2 | 2016-08-23 |
Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use App 20160151455 - Anantharamaiah; Gattadahalli M. ;   et al. | 2016-06-02 |
Peptides and Peptide Mimetics to Treat Pathologies Associated With Eye Disease App 20130295042 - Anantharamaiah; Gattadahalli M. ;   et al. | 2013-11-07 |
Peptides and peptide mimetics to treat pathologies associated with eye disease Grant 8,568,766 - Anantharamaiah , et al. October 29, 2 | 2013-10-29 |
Synthetic apolipoprotein E mimicking polypeptides and methods of use Grant 8,557,767 - Anantharamaiah , et al. October 15, 2 | 2013-10-15 |
Orally administered peptides synergize statin activity Grant 8,404,635 - Fogelman , et al. March 26, 2 | 2013-03-26 |
Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use App 20120245101 - Anantharamaiah; Gattadahalli M. ;   et al. | 2012-09-27 |
Orally Administered Peptides Synergize Statin Activity App 20120035095 - FOGELMAN; ALAN M. ;   et al. | 2012-02-09 |
G-type Peptides And Other Agents To Ameliorate Atherosclerosis And Other Pathologies App 20120004720 - Fogelman; Alan M. ;   et al. | 2012-01-05 |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response Grant 8,048,851 - Fogelman , et al. November 1, 2 | 2011-11-01 |
Peptides for treatment of scleroderma Grant 7,994,132 - Fogelman , et al. August 9, 2 | 2011-08-09 |
Peptides And Peptide Mimetics To Treat Pathologies Associated With Eye Disease App 20110182992 - Anantharamaiah; Gattadahalli M. ;   et al. | 2011-07-28 |
Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use App 20100298215 - Anantharamaiah; Gattadahalli M. ;   et al. | 2010-11-25 |
Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use App 20100286025 - Anantharamaiah; Gattadahalli M. ;   et al. | 2010-11-11 |
Orally administered peptides synergize statin activity Grant 7,820,784 - Fogelman , et al. October 26, 2 | 2010-10-26 |
Orally administered peptides synergize statin activity Grant 7,807,640 - Fogelman , et al. October 5, 2 | 2010-10-05 |
Peptides And Peptide Mimetics To Treat Pathologies Associated With Eye Disease App 20100143444 - Anantharamaiah; Gattadahalli M. ;   et al. | 2010-06-10 |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response Grant 7,723,303 - Fogelman , et al. May 25, 2 | 2010-05-25 |
Orally administered peptides synergize statin activity Grant 7,531,514 - Fogelman , et al. May 12, 2 | 2009-05-12 |
Orally Administered Peptides Synergize Statin Activity App 20080096815 - Fogelman; Alan M. ;   et al. | 2008-04-24 |
Orally Administered Peptides Synergize Statin Activity App 20080096814 - Fogelman; Alan M. ;   et al. | 2008-04-24 |
Orally Administered Peptides Synergize Statin Activity App 20080096816 - Fogelman; Alan M. ;   et al. | 2008-04-24 |
Orally administered peptides synergize statin activity App 20080045459 - Fogelman; Alan M. ;   et al. | 2008-02-21 |
Orally Administered Peptides Synergize Statin Activity App 20070254839 - Fogelman; Alan M. ;   et al. | 2007-11-01 |
Orally administered peptides synergize statin activity Grant 7,199,102 - Fogelman , et al. April 3, 2 | 2007-04-03 |
Orally administered small peptides synergize statin activity App 20070060527 - Fogelman; Alan M. ;   et al. | 2007-03-15 |
Orally administered peptides synergize statin activity Grant 7,166,578 - Fogelman , et al. January 23, 2 | 2007-01-23 |
Orally administered small peptides synergize statin activity Grant 7,148,197 - Fogelman , et al. December 12, 2 | 2006-12-12 |
Orally administered peptides to ameliorate atherosclerosis Grant 7,144,862 - Fogelman , et al. December 5, 2 | 2006-12-05 |
G-type peptides and other agents to ameliorate atherosclerosis and other pathologies App 20060205669 - Fogelman; Alan M. ;   et al. | 2006-09-14 |
Small molecules for the treatment of atherosclerosis App 20060173067 - Fogelman; Alan M. ;   et al. | 2006-08-03 |
Orally administered peptides to ameliorate atherosclerosis Grant 6,933,279 - Fogelman , et al. August 23, 2 | 2005-08-23 |
Orally administered small peptides synergize statin activity App 20050164950 - Fogelman, Alan M. ;   et al. | 2005-07-28 |
Orally administered peptides synergize statin activity App 20040266671 - Fogelman, Alan M. ;   et al. | 2004-12-30 |
Orally administered small peptides synergize statin activity App 20040254120 - Fogelman, Alan M. ;   et al. | 2004-12-16 |
Orally administered peptides to ameliorate atherosclerosis Grant 6,664,230 - Fogelman , et al. December 16, 2 | 2003-12-16 |
Orally administered peptides synergize statin activity App 20030229015 - Fogelman, Alan M. ;   et al. | 2003-12-11 |
Orally administered peptides to ameliorate atherosclerosis App 20030171277 - Fogelman, Alan M. ;   et al. | 2003-09-11 |
Orally administered peptides to ameliorate atherosclerosis App 20030045460 - Fogelman, Alan M. ;   et al. | 2003-03-06 |
Synthetic peptides that enhance atherogenic lipoprotein uptake and lower plasma cholesterol App 20020128175 - Anantharamaiah, Gattadahalli M. | 2002-09-12 |
Amphipathic peptides Grant 4,643,988 - Segrest , et al. February 17, 1 | 1987-02-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.